Professional Documents
Culture Documents
Name of The Drug
Name of The Drug
Indication Adjunct for treatment of tuberculosis with primary and secondary antitubercular drugs when these are not successful
Adverse Effects Common: myalgia, nausea, vomiting, arthralgia, anorexia. Serious: thrombocytopenia, hepatotoxicity, nephritis, porphyria, gout, hypersensitivity reactions.
Nursing Implication To minimize possible photosensitivity reaction, apply adequate sunscreen and use proper covering when exposed to strong sunlight. Notify treating physician if symptoms do not improve after several weeks on drug. Do not stop taking medication without consulting treating physician.
Clarithromycin
Pharyngitis/tonsillitis Acute maxillary sinusitis Acute exacerbation of chronic bronchitis (Streptococcus pneumoniae, Moraxella catarrhalis), pneumonia (S. pneumoniae, Mycoplasma pneumoniae) Acute exacerbation of chronic bronchitis (H. influenzae)
Common: diarrhea, nausea, abdominal pain. Severe: pseudomembranous colitis, ventricular arrhythmias, nephritis, cholestatic jaundice, angioedema. .
Use with caution in patients with liver or kidney dysfunction. Parameters to monitor Signs and symptoms of superinfection, in particular pseudomembranous colitis. Signs and symptoms of renal toxicity. Signs and symptoms of hearing impairment. Patients with Kidney or liver disease is at highest risk.
Rifampicin
Pulmonary tuberculosis: used in conjunction with other agents (combination therapy) Meningococcal prophylaxis Prophylaxis of Hemophilius influenzae type B infections
Common: diarrhea, red discoloration of urine and other body fluids. Serious: acute renal failure, confusion, bone marrow depression, hepatic injury.
Avoid driving or other activities requiring alertness until full response to rifampin or ripampicin is evaluated. Avoid alcohol. Rifampin may stain soft contact lenses permanently. Accordingly, soft contact lenses should not be worn during treatment with this drug. Do not discontinue taking rifampin without approval of treating physician.
Isoniazid
Primary treatment for active tuberculosis; firstline drug for combination therapy Prophylaxis against TB bacillus, prophylaxis following exposure: Drug of choice
Common: anorexia, nausea, abdominal pain, weakness. Serious: peripheral neuropathy, hepatitis, bone marrow suppression, seizures, depression, optic neuritis, blindness.
Acute liver disease, prior liver toxicity associated with INH therapy, severe hypersensitivity reaction to isoniazid(drug fever, arthritis).
Avoid alcohol. Drink 23 L of fluids/d. Report symptoms of drug side effects such as fatigue, anorexia, weakness (symptoms of hepatitis) to treating physician and stop drug. Continue therapy uninterrupted
to prevent relapse and spread Of infection . Food: Ideally, should be taken on an empty stomach; may administer with food if gastric irritation occurs. There may be a severe reaction if isoniazid is taken along with foods that contain large amounts of tyramine (eg, aged cheese, Chianti wine,pickled herring).